PLEASE EXPECT A PHONE CALL FROM THE PRACTICE TO CONFIRM APPOINTMENT REQUESTED.
Ashutosh Tewari is an accomplished and dedicated urologist treating his patients in New York City. Dr. Tewari is certified by the American Board of Urology and a member of the American Urological Association – New York, the Society of Urologic Oncology, the Society of Laparoscopic Surgeons, the Society of Robotic Surgery, and the New York Academy of Medicine. He is currently serving as a professor and chair in the department of urology at the Mount Sinai Hospital.
Dr. Tewari attended the Ganesh Shankar Vidyarthi Memorial Medical College in his native India. He also completed his surgical residency at this institution. Dr. Tewari relocated to the Henry Ford Hospital to complete his urology residency. Dr. Tewari completed three urology oncology fellowships at the University of California – San Francisco, the Henry Ford Hospital, and the University of Florida. In addition to these extensive research opportunities, Dr. Tewari completed a transplant fellowship at the University of Liverpool. Dr. Tewari is a prostate cancer specialist, with clinical expertise with laparoscopy, prostate biopsy, prostate-specific antigen (PSA) testing, prostatectomy, robot-assisted urologic procedures, as well as robotic prostate surgery.
Medical School - G.S.V.M. Medical College
G.S.V.M. Medical College, Residency in Surgery
Sanjay Gandhi Postgraduate Institute of Medical Sciences, Residency in Urology
University of Liverpool Faculty of Health and Life Sciences (Fellowship)
Henry Ford Hospital, Residency in Urology
Henry Ford Hospital, Fellowship in Urologic Oncology
University of Florida, Fellowship in Urologic Oncology
University of California, San Francisco, Fellowship in Urologic Oncology
American Board of Urology
Awards and Publications
2012 - First Prize Best Abstract EAU
2012 - Gold Cytoscope Award AUA
2011 - American Society of Clinical Oncology Merit Award ASCO GU
Knelson EH, Gaviglio AL, Tewari AK, Armstrong MB, Mythreye K, Blobe GC. Type III TGF-ß receptor promotes FGF2-mediated neuronal differentiation in neuroblastoma. The Journal of clinical investigation 2013 Oct.
Nguyen DP, Li J, Yadav SS, Tewari AK. Recent insights into NF-kB signalling pathways and the link between inflammation and prostate cancer. BJU international 2013 Oct.